Italy's New Govt Seeking More Drug Spending Cuts?
Italy's state pharmaceutical spending is again among the areas likely to get the axe, as the new center-left government, headed by Romano Prodi, tries to put together a further 15,000 billion lire ($9.67 billion) package aimed at constraining the 1996 budget deficit within the 109,400 billion lire ($70.53 billion) ceiling set by the previous government.
The measures will be made official by June 20, just ahead of the European Union Summit to be held in Florence, and which will mark the end of Italy's tenure of the EU presidency.
However, according to rumors in the press and in political circles, the Health Ministry, headed by Rosy Bindi, is studying pharmaceutical spending cuts amounting to around 1,300 billion lire.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze